Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients.

In this study, serum sclerostin level, but not DKK1, is found to be positively correlated with cfPWV values and is identified as an independent predictor of arterial stiffness in hypertensive patients after adjusting for significant confounders.